These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 7256167

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. High level of human growth hormone (HGH) in cerebrospinal fluid patients with pituitary tumors.
    Coculescu M, Simionescu L, Constantinovici A, Login SS, Simionescu N, Dimitriu V, Oprescu M, Grigorescu F.
    Endocrinologie; 1979; 17(3):205-11. PubMed ID: 504962
    [Abstract] [Full Text] [Related]

  • 5. [Endocrinological evaluation of sellar and suprasellar tumor cases (the ninth report)--on the PRL levels in the CSF (author's transl)].
    Matsumura S, Mori S, Yoshimoto H, Ohta M, Uozumi T.
    No Shinkei Geka; 1977 Sep; 5(10):1057-63. PubMed ID: 909617
    [Abstract] [Full Text] [Related]

  • 6. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
    Teramoto A, Sanno N, Tahara S, Osamura YR.
    Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
    [Abstract] [Full Text] [Related]

  • 7. Cerebrospinal fluid prolactin: a reflection of abnormal prolactin secretion in patients with pituitary tumors.
    Schroeder LL, Johnson JC, Malarkey WB.
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1255-60. PubMed ID: 1002815
    [Abstract] [Full Text] [Related]

  • 8. Bromocriptine treatment of pituitary adenomas. Evaluation of withdrawal effect.
    Coculescu M, Simionescu N, Oprescu M, Alessandrescu D.
    Endocrinologie; 1983 Dec; 21(3):157-68. PubMed ID: 6635518
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
    Abbassioun K, Amirjamshidi M, Mehrazin A, Khalatbary I, Keynama M, Bokai H, Abdollahi M.
    Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
    [Abstract] [Full Text] [Related]

  • 12. Transsphenoidal adenomectomy for GH-, PRL- and ACTH-secreting pituitary tumours: outcome analysis in a series of 125 patients.
    Esposito V, Santoro A, Minniti G, Salvati M, Innocenzi G, Lanzetta G, Cantore G.
    Neurol Sci; 2004 Dec; 25(5):251-6. PubMed ID: 15624082
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas.
    Kristof RA, Schramm J, Redel L, Neuloh G, Wichers M, Klingmüller D.
    Acta Neurochir (Wien); 2002 Jun; 144(6):555-61; discussion 561. PubMed ID: 12111488
    [Abstract] [Full Text] [Related]

  • 18. Infertility in patients with hyperprolactinemia from a pituitary adenoma. Effect of transsphenoidal pituitary adenectomy.
    Dolman LI, Roberts TS, Poulson M, Tyler FH.
    Arch Intern Med; 1977 Sep; 137(9):1161-4. PubMed ID: 901084
    [Abstract] [Full Text] [Related]

  • 19. Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro.
    Winczyk K, Kunert-Radek J, Gruszka A, Radek M, Ławnicka H, Pawlikowski M.
    Neuro Endocrinol Lett; 2009 Mar; 30(1):107-10. PubMed ID: 19300395
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.